Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic?
Bayer
Arnold S
AS
Murray
Barbara E
BE
D000617:Aminoglycosides / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D016896:Treatment Outcome
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents